Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 05, 2015 8:22 AM ET

Life Sciences Tools and Services

Company Overview of Prolexys Pharmaceuticals, Inc.

Key Executives for Prolexys Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Sudhir R. Sahasrabudhe Ph.D.3 RelationshipsScientific Founder, Acting Chief Executive Officer, Chief Scientific Officer and Director54
Chad Bello No RelationshipsDirector of Finance--
Tracy H. Erkkila No RelationshipsVice President of Drug Discovery Operations--

Prolexys Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Friedli 22 RelationshipsOsiris Therapeutics, Inc.61
Sudhir R. Sahasrabudhe Ph.D. 3 RelationshipsProlexys Pharmaceuticals, Inc.54
Yasuhiro Moriuchi 3 RelationshipsProlexys Pharmaceuticals, Inc.--
Tadashi Hirose 3 RelationshipsProlexys Pharmaceuticals, Inc.--
View All Board Members

Prolexys Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
393.0K
Bonus
345.8K
Total Short Term Compensation
511.8K
Total Value of Options
25.8M
Compensation as of Fiscal Year
Prolexys Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Composition of Suominen's Nomination Board
September 02, 2015 6:30 AM ET
Michael C Feenan Joins SCA as Vice President of Personal Care Business in North America
August 26, 2015 10:30 AM ET
Alissa Sears to Join Aunt Fannie's, Inc.'s Board of Advisors
August 24, 2015 1:22 PM ET
The National Detergent Co. SAOG Announces Board Changes
August 20, 2015 10:16 AM ET
Kimberly-Clark Corporation Announces Resignation of Linda Johnson Rice from the Board of Directors
August 18, 2015 8:42 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prolexys Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.